Navigation Links
Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
Date:1/11/2010

SAN DIEGO, Jan 11 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it expects total revenues for fiscal 2009 will be approximately $228.0 million, with revenues in the fourth quarter of fiscal 2009 expected to be approximately $71.0 million.

The revenue expectations for fiscal 2009 compare with the company's prior guidance for fiscal 2009 revenues of $218.0-$223.0 million, and reflect year-over-year revenue growth of approximately 33 percent. The expectations for revenues in the fourth quarter of 2009 represent an increase of approximately 44 percent over revenues in the fourth quarter of 2008. The results for the full year and fourth quarter of 2009 include revenues of approximately $18.0 million and $5.8 million, respectively, from Axsun Technologies, Inc., which Volcano acquired at the end of 2008, and for which the company recorded no meaningful revenues in either period during 2008.

"Our financial performance for the quarter was driven by strong growth across our core businesses and in our key geographies. In particular, we saw growth in capital equipment sales in the U.S. and Europe and continued adoption of our IVUS (Intravascular Ultrasound) and FM (Functional Measurement) disposables. In addition, we benefitted from our going direct transition in Japan," noted Scott Huennekens, president and chief executive officer of Volcano.

The company said it was providing the updated revenue projections for 2009 in advance of meetings with the investment community and a presentation at the 28th Annual J.P. Morgan Healthcare Conference this week. The company's presentation will occur at 2 p.m., Pacific Standard Time (5 p.m. Eastern Standard Time), on Tuesday, January 12, and will be available through the conference website at http://metameetings.com/webcasts/jpmorgan/healthcare10/directlink?ticker=VOLC and via the company's website at www.volcanocorp.com.

The company's fourth quarter and full-year 2009 operating and financial performance and guidance for fiscal 2010 will be provided in a press release, as well as in a conference call and webcast open to all interested parties, in early March. Details of the earnings release date, conference call and webcast will be provided in a subsequent release.

About Volcano

Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH® IVUS tissue characterization and ChromaFlo®. Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography and Forward-Looking IVUS systems and catheters. Currently, more than 4,700 Volcano IVUS and FM systems are installed worldwide, and more than half of Volcano's revenues are derived from outside the United States. Through its wholly-owned subsidiary, Axsun Technologies, Volcano also develops and manufactures optical monitors, lasers and optical engines used in telecommunications, spectroscopy and other industrial applications. For more information, visit the company's website at http://www.volcanocorp.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this press release regarding Volcano's business that are not historical facts may be "forward-looking statements" that involve risks and uncertainties. Specifically, statements concerning Volcano's expected revenues and revenue growth for the fourth quarter and fiscal year ended December 31, 2009, are forward looking statements involving risks and uncertainties as Volcano's 2009 financial results, including revenues, have not been audited. These statements are being made prior to the completion of Volcano's accounting close procedures for the fiscal year ended December 31, 2009, and are therefore subject to modification. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Volcano's results to differ materially from the statements contained herein. The potential risks and uncertainties that could cause actual results to differ from the results predicted are detailed in the company's reports and other filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

SOURCE Volcano Corporation

RELATED LINKS
http://www.volcanocorp.com

'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
2. Volcano Announces Installed Base Growth Milestone
3. Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging
4. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
5. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
6. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
7. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
8. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
9. Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010
10. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
11. Baxa Corporation to Sponsor Free Culture of Safety Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening to conquer ... in advanced audiology and hearing aid technology, has today ... world,s first internet connected hearing aid that opens up ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... , TwinLink™ - the first dual communication ...
(Date:6/23/2016)... The vast majority of dialysis patients currently ... are usually 3 times a week, with treatment times ... time, equipment preparation and wait time.  This regimen can ... patients who are elderly and frail.  Many elderly dialysis ... centers for some duration of time. Residents ...
Breaking Medicine Technology:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):